Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Dr.Kay is a highly experienced pharmaceutical professional with expertise in respiratory drug development spanning from early clinical through pivotal phase III programs. Kay was an outstanding mentor while working together on early translational clinical projects and multinational phase IIa PoC studies. He is the Senior Clinical Program Leader, Therapeutic Area Respiratory in Boehringer Ingelheim.
Allergology, Pulmonology, Respiratory Medicine, Respiratory drugs, Lung diseases, Lung, Pulmonary diseases
Research Article: J Pulm Respir Med 2014, 4: 196
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals